These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 34226680)
1. MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer. Lampis A; Hahne JC; Gasparini P; Cascione L; Hedayat S; Vlachogiannis G; Murgia C; Fontana E; Edwards J; Horgan PG; Terracciano L; Sansom OJ; Martins CD; Kramer-Marek G; Croce CM; Braconi C; Fassan M; Valeri N Cell Death Differ; 2021 Oct; 28(10):2970-2982. PubMed ID: 34226680 [TBL] [Abstract][Full Text] [Related]
2. Effect of junctional adhesion molecule-2 expression on cell growth, invasion and migration in human colorectal cancer. Zhao H; Yu H; Martin TA; Zhang Y; Chen G; Jiang WG Int J Oncol; 2016 Mar; 48(3):929-36. PubMed ID: 26782073 [TBL] [Abstract][Full Text] [Related]
3. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. McSherry EA; Brennan K; Hudson L; Hill AD; Hopkins AM Breast Cancer Res; 2011 Mar; 13(2):R31. PubMed ID: 21429211 [TBL] [Abstract][Full Text] [Related]
4. Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings. Leech AO; Vellanki SH; Rutherford EJ; Keogh A; Jahns H; Hudson L; O'Donovan N; Sabri S; Abdulkarim B; Sheehan KM; Kay EW; Young LS; Hill ADK; Smith YE; Hopkins AM Breast Cancer Res; 2018 Nov; 20(1):140. PubMed ID: 30458861 [TBL] [Abstract][Full Text] [Related]
5. DC-SIGN-LEF1/TCF1-miR-185 feedback loop promotes colorectal cancer invasion and metastasis. Yuan M; Zhang X; Zhang J; Wang K; Zhang Y; Shang W; Zhang Y; Cui J; Shi X; Na H; Fang D; Zuo Y; Ren S Cell Death Differ; 2020 Jan; 27(1):379-395. PubMed ID: 31217502 [TBL] [Abstract][Full Text] [Related]
7. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma. Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044 [TBL] [Abstract][Full Text] [Related]
8. The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression. Czubak-Prowizor K; Babinska A; Swiatkowska M Mol Cell Biochem; 2022 Jan; 477(1):79-98. PubMed ID: 34533648 [TBL] [Abstract][Full Text] [Related]
9. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression. Murakami M; Giampietro C; Giannotta M; Corada M; Torselli I; Orsenigo F; Cocito A; d'Ario G; Mazzarol G; Confalonieri S; Di Fiore PP; Dejana E PLoS One; 2011; 6(6):e21242. PubMed ID: 21695058 [TBL] [Abstract][Full Text] [Related]
10. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer. Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702 [TBL] [Abstract][Full Text] [Related]
11. Junctional adhesion molecule-A, an epithelial-mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer. Tian Y; Tian Y; Zhang W; Wei F; Yang J; Luo X; Zhou T; Hou B; Qian S; Deng X; Qiu Y; Yao K Carcinogenesis; 2015 Jan; 36(1):41-8. PubMed ID: 25416560 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression. Zhang M; Luo W; Huang B; Liu Z; Sun L; Zhang Q; Qiu X; Xu K; Wang E PLoS One; 2013; 8(11):e79173. PubMed ID: 24265754 [TBL] [Abstract][Full Text] [Related]
13. JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide. Xu PP; Sun YF; Fang Y; Song Q; Yan ZX; Chen Y; Jiang XF; Fei XC; Zhao Y; Leboeuf C; Li B; Wang CF; Janin A; Wang L; Zhao WL Sci Rep; 2017 Aug; 7(1):7433. PubMed ID: 28785100 [TBL] [Abstract][Full Text] [Related]
14. Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans. Brandl A; Solimando AG; Mokhtari Z; Tabares P; Medler J; Manz H; Da Vià MC; Croci GA; Kurzwart M; Thusek S; Schneider T; Ebert R; Jakob F; Einsele H; Beilhack A Blood Adv; 2022 Apr; 6(7):2195-2206. PubMed ID: 34861679 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of junctional adhesion molecule-A contributes to ethanol-induced barrier disruption in intestinal epithelial cell monolayers. Chopyk DM; Kumar P; Raeman R; Liu Y; Smith T; Anania FA Physiol Rep; 2017 Dec; 5(23):. PubMed ID: 29208693 [TBL] [Abstract][Full Text] [Related]
16. Junctional adhesion molecule C (JAM-C) dimerization aids cancer cell migration and metastasis. Garrido-Urbani S; Vonlaufen A; Stalin J; De Grandis M; Ropraz P; Jemelin S; Bardin F; Scheib H; Aurrand-Lions M; Imhof BA Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):638-649. PubMed ID: 29378216 [TBL] [Abstract][Full Text] [Related]
18. miR-543 promoted the cell proliferation and invasion of nasopharyngeal carcinoma by targeting the JAM-A. Jiang X; Dai B; Feng L Hum Cell; 2019 Oct; 32(4):477-486. PubMed ID: 31428943 [TBL] [Abstract][Full Text] [Related]
19. JAM-A expression positively correlates with poor prognosis in breast cancer patients. McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747 [TBL] [Abstract][Full Text] [Related]
20. LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A. Dai BQ; Jiang X; Feng LC Kaohsiung J Med Sci; 2021 May; 37(5):361-370. PubMed ID: 33400379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]